Enzychem Lifesciences To Present At Biotech Showcase™ 2020 In San FranciscoHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Enzychem Lifesciences To Present At Biotech Showcase™ 2020 In San FranciscoPR NewswireJanuary 6, 2020ReblogShareTweetShareENGLEWOOD, N.J., Jan. 6, 2020 /PRNewswire/ -- Enzychem Lifesciences, a leading global biopharmaceutical company focusing on innovative new drug development for unmet medical needs, today announced that it will present at Biotech Showcase™ 2020, to be held January 13–15, 2020, during the most important week in healthcare at the Hilton San Francisco Union Square.(PRNewsfoto/Enzychem Lifesciences)MoreChief Medical Officer, Dr. Myung Hwan Kim will present at Biotech Showcase™ as follows:Date: Tuesday, January 14, 2020 Time: 3:30 PM  Room: Franciscan A (Ballroom Level) Location: Hilton San Francisco Union Square Hotel, 333 O'Farrell Street, San Francisco, CABiotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and executives in one place during the course of one of the industry's largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.About Enzychem Lifesciences CorporationEnzychem Lifesciences, Corp. (KOSDAQ: 183490) is a global biopharmaceutical company headquartered in Seoul, Korea, which is dedicated to developing new drugs and Active Pharmaceutical Ingredients (APIs). Since its foundation in 1999, Enzychem Lifesciences has been striving to develop innovative treatments for patients with unmet medical needs. The company's lead compound (EC-18) is an immune resolution accelerator, derived from Sika deer antler that has the potential to be used for a variety of indications. For more information, please visit: http://www.enzychem.com/Media Contact: Ted Kim (Manager of Business Development)Email: ted.kim@enzychem.com CisionMoreView original content to download multimedia:http://www.prnewswire.com/news-releases/enzychem-lifesciences-to-present-at-biotech-showcase-2020-in-san-francisco-300981619.htmlSOURCE Enzychem LifesciencesReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextFacebook Cancels Annual Conference Due to Coronavirus Concerns: 'This Was a Tough Call to Make'People'Dispatches From Elsewhere': a crazy real-life 'game' comes to TVAFPRegulators boost PG&E's wildfire fine to $2.1 billionAssociated PressWould You Live in an Adult Dorm? One Silicon Valley Startup Is Renting Out Shared RoomsHouse BeautifulBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo Finance